logo

HALEOSLABS vs SOLARA: Stock Comparison

HALEOS LABS vs SOLARA ACTIVE PHA SCIUpdated 22 Oct 26, 4:08 PM ISTNSE & company filings

SOLARA ACTIVE PHA SCI is the larger company by market capitalisation. HALEOS LABS shows a lower P/E, a higher ROE and a higher dividend yield, while SOLARA ACTIVE PHA SCI shows faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

HALEOSLABS leads 8; SOLARA leads 4 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

HALEOSLABSSOLARA

Valuation lens

What price are you paying?

Market CapContext only
₹490 Cr
₹3,011 Cr
P/E RatioHALEOSLABS has the lower reading
29.35x ✓
81.57x
P/B RatioSOLARA has the lower reading
2.17x
2.09x ✓
EPSHALEOSLABS has the higher reading
₹8.75 ✓
₹5.9
Book ValueContext only
₹759.29
₹260.24
Dividend YieldHALEOSLABS has the higher reading
0.09% ✓
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
SOLARA is the larger company
₹3,011 Cr vs ₹490 Cr
P/E Ratio
HALEOSLABS has a lower P/E
29.35x vs 81.57x
P/B Ratio
SOLARA has a lower P/B
2.09x vs 2.17x
EPS
HALEOSLABS has higher earnings per share
₹8.75 vs ₹5.9
Dividend Yield
HALEOSLABS has a higher dividend yield
0.09% vs 0%
Revenue Growth (TTM YoY)
SOLARA has faster revenue growth
41.9% vs 0%
Qtr Sales Growth
SOLARA has stronger quarterly sales growth
9.37% vs 0%
Qtr Profit Growth
SOLARA has stronger quarterly profit growth
74.49% vs 0%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricHALEOSLABSSOLARA
Sector—Healthcare
Industry—Pharmaceuticals

Price

MetricHALEOSLABSSOLARA
Live Price₹1,611.3₹619.05
Day Change1.74%-4.5%
Volume8954.56 L
52-Week High₹1,774₹774
52-Week Low₹1,181₹422
Distance from 52W High-9.17%-20.02%

Valuation

MetricHALEOSLABSSOLARA
Market Cap₹490 Cr₹3,011 Cr
P/E Ratio29.35x81.57x
P/B Ratio2.17x2.09x
EPS₹8.75₹5.9
Book Value₹759.29₹260.24
Dividend Yield0.09%0%

Growth

MetricHALEOSLABSSOLARA
Revenue Growth (TTM YoY)0%41.9%
EPS Growth (TTM YoY)0%0%
Qtr Sales Growth0%9.37%
Qtr Profit Growth0%74.49%

Profitability & Leverage

MetricHALEOSLABSSOLARA
ROE7.75%-0.59%
ROCE6.63%4.56%
Net Margin5.33%-0.54%
Operating Margin9.48%6.38%
Debt to Equity0.47x0.53x

Shareholding

As of Sep 2026 • change vs previous quarter
MetricHALEOSLABSSOLARA
Promoter Holding72.11%41.93%▼ 0.07 pp
FII Holding0%11.52%▲ 0.19 pp
DII Holding0.31%3.74%▼ 0.04 pp
Public Holding27.58%42.81%▼ 0.08 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: HALEOS LABS and SOLARA ACTIVE PHA SCI.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.